Insulet (PODD) Total Liabilities (2010 - 2026)
Insulet's (PODD) quarterly Total Liabilities came in at $1.7 billion in Q2 2026, down 13.13% on a YoY basis from $2.0 billion in Q2 2025, and up 3.46% quarter-over-quarter from $1.7 billion in Q1 2026.
Analysis
Insulet (PODD) Total Liabilities (2010 - 2026) Analysis & Trends
Insulet (PODD) has reported Total Liabilities for 17 consecutive years, with $1.7 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Liabilities fell 13.13% year-over-year to $1.7 billion; the trailing twelve-month figure through Jun 2026 stood at $1.7 billion (down 13.13% YoY), and the FY2025 full-year result was $1.7 billion, down 10.71% from the prior year.
- Total Liabilities climbed to $1.7 billion in Q2 2026 per PODD's latest filing, from $1.7 billion in the prior quarter.
- Across five years, Total Liabilities topped out at $2.2 billion in Q1 2025 and bottomed at $1.6 billion in Q1 2022.
- Historically, Total Liabilities has averaged $1.8 billion across 5 years, with a median of $1.8 billion in 2023.
- The sharpest annual moves came in 2022 and 2026: Total Liabilities gained 29.3% in 2022, then decreased 22.96% in 2026.
- Over 5 years, Total Liabilities stood at $1.8 billion in 2022, then climbed by 4.55% to $1.9 billion in 2023, then increased by 1.11% to $1.9 billion in 2024, then retreated by 10.71% to $1.7 billion in 2025, then rose by 4.04% to $1.7 billion in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $1.7 billion, $1.7 billion, and $1.7 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.76 Bn | 175.16 Bn | 7.27 Bn | 57.45 Bn |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | 2.58 Bn |
| 3 | Medtronic | 117.20 Bn | 108.39 Bn | 6.34 Bn | 42.46 Bn |
| 4 | Stryker | 104.01 Bn | 100.53 Bn | 4.50 Bn | 23.94 Bn |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn | 20.04 Bn |
| 6 | Edwards Lifesciences | 49.80 Bn | 45.55 Bn | 1.35 Bn | 3.14 Bn |
| 7 | Alcon | 33.03 Bn | 31.58 Bn | 1.68 Bn | 9.50 Bn |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | 3.83 Bn |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 3.51 Bn |
| 10 | Insulet | 9.35 Bn | 8.82 Bn | 562.60 Mn | 1.74 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.74 Bn |
| Mar 31, 2026 | 1.68 Bn |
| Dec 31, 2025 | 1.68 Bn |
| Sep 30, 2025 | 1.65 Bn |
| Jun 30, 2025 | 2.01 Bn |
| Mar 31, 2025 | 2.19 Bn |
| Dec 31, 2024 | 1.88 Bn |
| Sep 30, 2024 | 1.91 Bn |
| Jun 30, 2024 | 1.88 Bn |
| Mar 31, 2024 | 1.83 Bn |
| Dec 31, 2023 | 1.86 Bn |
| Sep 30, 2023 | 1.86 Bn |
| Jun 30, 2023 | 1.83 Bn |
| Mar 31, 2023 | 1.79 Bn |
| Dec 31, 2022 | 1.77 Bn |
| Sep 30, 2022 | 1.74 Bn |
| Jun 30, 2022 | 1.69 Bn |
| Mar 31, 2022 | 1.62 Bn |
| Dec 31, 2021 | 1.49 Bn |
| Sep 30, 2021 | 1.50 Bn |